首页 | 本学科首页   官方微博 | 高级检索  
     

子宫动脉栓塞术治疗子宫肌瘤22例
引用本文:郭卫平,张洪新,倪代会,王执民,王义清,李文献,刘燕,韩瑞炀. 子宫动脉栓塞术治疗子宫肌瘤22例[J]. 医学争鸣, 2001, 22(7): 623-626
作者姓名:郭卫平  张洪新  倪代会  王执民  王义清  李文献  刘燕  韩瑞炀
作者单位:第四军医大学唐都医院介入放射科,;第四军医大学唐都医院介入放射科,;第四军医大学唐都医院介入放射科,;第四军医大学唐都医院介入放射科,;第四军医大学唐都医院介入放射科,;第四军医大学唐都医院介入放射科,;第四军医大学唐都医院介入放射科,;第四军医大学唐都医院介入放射科,
摘    要:目的 对不同类型子宫肌瘤进行子宫动脉栓塞治疗的临床应用研究 ,了解此方法疗效、副反应及并发症 ,探索治疗子宫肌瘤的新方法 .方法 对 2 2例以子宫出血、月经失常、贫血、下腹包块等为主要表现的子宫肌瘤患者进行双侧子宫动脉栓塞 (1次 ,碘化油用量以瘤染色消失为限 ) ,随访复查瘤体大小、出血多少、月经、贫血等方面的变化 .结果 随访 12 m o,瘤块均有不同程度的缩小 [其中 ,粘膜下肌瘤由术前 (8.7± 1.2 )cm缩小至 (2 .0± 0 .9) cm,P<0 .0 1;肌壁间肌瘤由术前 (7.2± 0 .8) cm缩小至 (1.4± 0 .4) cm,P<0 .0 1;浆膜下肌瘤由术前 (6 .4± 0 .9) cm缩小至 (2 .0± 0 .7) cm,P<0 .0 1],所有子宫出血病例 ,月经恢复正常 ;贫血病例 ,血红蛋白升至正常范围[其中 ,粘膜下肌瘤由术前 (7.2± 1.7) cm升至 (13.7± 1.9) g· L- 1 ,P<0 .0 1;肌壁间肌瘤由术前 (9.8± 0 .6 ) g· L- 1升至(13.6± 1.8) g· L- 1 ,P<0 .0 1;浆膜下肌瘤由术前 (10 .5± 1.2 ) g· L- 1 升至 (14.0± 2 .6 ) g· L- 1 ,P<0 .0 1].无严重并发症发生 .结论 子宫动脉栓塞术是治疗各类子宫肌瘤的安全、有效的新方法 ,对于想保留子宫、不愿手术、有手术禁忌证等情况的子宫肌瘤患者 ,不失为良好的选择 .

关 键 词:子宫肌瘤  子宫动脉  栓塞  治疗性
文章编号:1000-2790(2001)07-0623-04
修稿时间:2000-11-27

Uterine arterial embolization therapy for 22 patients with hysteromyoma
GUO Wei-Pign,ZHANG Hong-Xin,NI Dai-Hui,WANG Zhi-Ming,WANG Yi-qing,LI Wen-Xian,LIU Yan,HAN Rui-Yang. Uterine arterial embolization therapy for 22 patients with hysteromyoma[J]. Negative, 2001, 22(7): 623-626
Authors:GUO Wei-Pign  ZHANG Hong-Xin  NI Dai-Hui  WANG Zhi-Ming  WANG Yi-qing  LI Wen-Xian  LIU Yan  HAN Rui-Yang
Abstract:AIM To assess the curative effects, side effectsand complications of uterine arterial embolizartion therapy for hysteromyoma. METHODS Bilateral uterine arterial embolization (only once, moderate lipidol until the imaging of tumor disppeared) was performed on 22 patients suffering from hysteromyoma with the signs of uterine hemorrhage, anemia or abdomenal mass, menorhagia. Changes of the amount of uterine hemorrhage, the seriousness of anemia and the size of tumors were observed during follow-up checkups. RESULTS 12 months after the treatment, the tumors in all cases were found shrunk in varied degrees [submucous reduced from (8.7±1.2) to (2.0±0.9) cm, P<0.01; leiomyoma reduced from (7.2±0.8) to (1.4±0.4) cm, P<0.01; reduced from (6.4±0.9) to (2.0±0.7) cm, P<0.01]. Abnormal uterine hemorrhage and anemia disappeared [submucousd increased from (7.2±1.7) to (13.7±1.9) g*L-1, P<0.01; leiomyoma increased from (9.8±0.6) to (13.6±1.8) g*L-1, P<0.01; subserous increased from (10.5±1.2) to (14.0±2.6) g*L-1, P<0.01]. No serious complications occurred. CONCLUSION Uterine arterial embolization, a safe and effective therapy, might be the first choice for the patients who are unwilling to run the risk of a surgery, to keep their utenus, or suffer from some contraindictions.
Keywords:hysteromyoma  uterine arterial  embolization   therapeutic
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号